Emory Ryan

599 total citations
23 papers, 383 citations indexed

About

Emory Ryan is a scholar working on Physiology, Cell Biology and Molecular Biology. According to data from OpenAlex, Emory Ryan has authored 23 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 17 papers in Cell Biology and 7 papers in Molecular Biology. Recurrent topics in Emory Ryan's work include Lysosomal Storage Disorders Research (21 papers), Cellular transport and secretion (17 papers) and Studies on Chitinases and Chitosanases (5 papers). Emory Ryan is often cited by papers focused on Lysosomal Storage Disorders Research (21 papers), Cellular transport and secretion (17 papers) and Studies on Chitinases and Chitosanases (5 papers). Emory Ryan collaborates with scholars based in United States, Czechia and Canada. Emory Ryan's co-authors include Ellen Sidransky, Sam E. Gary, Grisel Lopez, Pankaj Sharma, Michele R. Filling‐Katz, Nahid Tayebi, Gerald E. Marti, N M Papadopoulos, H. R. Gralnick and Norman W. Barton and has published in prestigious journals such as Neurology, European Heart Journal and Movement Disorders.

In The Last Decade

Emory Ryan

21 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emory Ryan United States	9	332	218	123	93	74	23	383
Mario A. Cabrera-Salazar United States	10	325 1.0×	155 0.7×	169 1.4×	69 0.7×	100 1.4×	11	396
C. Martini Italy	9	252 0.8×	135 0.6×	80 0.7×	54 0.6×	87 1.2×	12	358
Robert McGlynn United States	5	245 0.7×	107 0.5×	74 0.6×	56 0.6×	72 1.0×	6	333
Emerson Maniwang United States	6	258 0.8×	151 0.7×	71 0.6×	54 0.6×	73 1.0×	6	343
Karen M. Ashe United States	8	308 0.9×	122 0.6×	151 1.2×	87 0.9×	122 1.6×	9	390
Ashley N. Gonzalez United States	6	206 0.6×	125 0.6×	87 0.7×	47 0.5×	83 1.1×	13	335
Heather Cahan United States	7	265 0.8×	115 0.5×	119 1.0×	19 0.2×	64 0.9×	16	418
Barbara Tappino Italy	10	180 0.5×	89 0.4×	161 1.3×	47 0.5×	84 1.1×	16	361
Aiyin Liao United Kingdom	8	270 0.8×	119 0.5×	149 1.2×	23 0.2×	80 1.1×	14	376
Megan A. Griffey United States	6	359 1.1×	227 1.0×	202 1.6×	24 0.3×	77 1.0×	6	469

Countries citing papers authored by Emory Ryan

Since Specialization

Citations

This map shows the geographic impact of Emory Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emory Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emory Ryan more than expected).

Fields of papers citing papers by Emory Ryan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emory Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emory Ryan. The network helps show where Emory Ryan may publish in the future.

Co-authorship network of co-authors of Emory Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Emory Ryan. A scholar is included among the top collaborators of Emory Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emory Ryan. Emory Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sidransky, Ellen, et al.. (2025). Obstacles to Early Diagnosis of Gaucher Disease. Therapeutics and Clinical Risk Management. Volume 21. 93–101. 1 indexed citations

Ryan, Emory, et al.. (2024). Phenotypic consequences of GBA1 pathological variant R463C (p.R502C). American Journal of Medical Genetics Part A. 194(9). e63630–e63630.

Do, Jenny, Emory Ryan, Nahid Tayebi, et al.. (2023). An exploration of knowledge, risk perceptions, and communication in a family with multiple genetic risks for Parkinson's disease. Journal of Genetic Counseling. 32(3). 750–757. 1 indexed citations

Ryan, Emory, et al.. (2022). Facial features of lysosomal storage disorders. Expert Review of Endocrinology & Metabolism. 17(6). 467–474. 3 indexed citations

Ryan, Emory, et al.. (2022). Newborn Screening in Gaucher Disease: A Bright and Complicated Future. 6(3). 1–21. 3 indexed citations

Lopez, Grisel, et al.. (2022). Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's disease. Frontiers in Neurology. 13. 1039214–1039214. 4 indexed citations

Ginns, Edward I., Emory Ryan, & Ellen Sidransky. (2021). Gaucher disease in the COVID-19 pandemic environment: The good, the bad and the unknown. Molecular Genetics and Metabolism. 132(4). 213–214. 7 indexed citations

Ryan, Emory, et al.. (2021). Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes. Molecular Genetics and Metabolism. 132(2). 49–58. 38 indexed citations

Fleischer, Nicole, et al.. (2021). Investigation of a dysmorphic facial phenotype in patients with Gaucher disease types 2 and 3. Molecular Genetics and Metabolism. 134(3). 274–280. 4 indexed citations

10.

Ryan, Emory, et al.. (2021). Current and emerging pharmacotherapy for Gaucher disease in pediatric populations. Expert Opinion on Pharmacotherapy. 22(11). 1489–1503. 21 indexed citations

11.

Inati, Sara K., Nahid Tayebi, Barbara Stubblefield, et al.. (2020). EEG abnormalities in patients with chronic neuronopathic Gaucher disease: A retrospective review. Molecular Genetics and Metabolism. 131(3). 358–363. 8 indexed citations

12.

Ryan, Emory, et al.. (2020). The natural history of type 2 Gaucher disease in the 21st century. Neurology. 95(15). e2119–e2130. 31 indexed citations

13.

Ryan, Emory, Dominick Amato, Jennifer MacKenzie, Ellen Sidransky, & Grisel Lopez. (2020). Parkinsonism in Patients with Neuronopathic (Type 3) Gaucher Disease: A Case Series. Movement Disorders Clinical Practice. 7(7). 834–837. 7 indexed citations

14.

Ryan, Emory, et al.. (2019). Mutations, modifiers and epigenetics in Gaucher disease: Blurred boundaries between simple and complex disorders. Molecular Genetics and Metabolism. 128(1-2). 10–13. 10 indexed citations

15.

Ryan, Emory, et al.. (2019). GBA1-associated parkinsonism: new insights and therapeutic opportunities. Current Opinion in Neurology. 32(4). 589–596. 42 indexed citations

16.

Solomon, Beth, et al.. (2019). Five-parameter evaluation of dysphagia: A novel prognostic scale for assessing neurological decline in Gaucher disease type 2. Molecular Genetics and Metabolism. 127(3). 191–199. 7 indexed citations

17.

Lopez, Grisel, Emory Ryan, Catherine Groden, et al.. (2019). Clinical Evaluation of Sibling Pairs With Gaucher Disease Discordant for Parkinsonism. Movement Disorders. 35(2). 359–365. 12 indexed citations

18.

Gary, Sam E., et al.. (2018). Recent advances in the diagnosis and management of Gaucher disease. Expert Review of Endocrinology & Metabolism. 13(2). 107–118. 95 indexed citations

19.

Ryan, Emory. (2003). P3254 Anaemia in a heart failure disease management program: Iron deficiency or anaemia of chronic disease?. European Heart Journal. 24(5). 614–614. 1 indexed citations

20.

Marti, Gerald E., Emory Ryan, N M Papadopoulos, et al.. (1988). Polyclonal B‐cell lymphocytosis and hypergammaglobulinemia in patients with gaucher disease. American Journal of Hematology. 29(4). 189–194. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact